Home  /  Resource Library  /  Complete responses to odronextamab in two patients with diffuse large B-cell lymphoma refractory to chimeric antigen receptor T-cell therapy

Complete responses to odronextamab in two patients with diffuse large B-cell lymphoma refractory to chimeric antigen receptor T-cell therapy

Case report of two patients with DLBCL refractory to CAR-T therapy who were treated with bispecific Odronextamab.